Publicaciones en colaboración con investigadores/as de Università degli Studi di Siena (49)

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery

    BMC Psychiatry, Vol. 23, Núm. 1

  3. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  4. First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

    Journal for immunotherapy of cancer, Vol. 11, Núm. 2

  5. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

  6. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients

    Cancers, Vol. 15, Núm. 17

  7. Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR

    European Heart Journal Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1052-1061

  8. Variation in delivery room management of preterm infants across Europe: a survey of the Union of European Neonatal and Perinatal Societies

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4173-4183